ARVN Arvinas Inc

Price (delayed)

$7.76

Market cap

$500.68M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.18

Enterprise value

$421.78M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 16
Relative Valuation: Rel. Valuation: 13
Relative Profitability: Rel. Profitability: 25

Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing ...

Highlights
The debt has declined by 20% year-on-year and by 6% since the previous quarter
The quick ratio is up by 19% year-on-year and by 11% since the previous quarter
The EPS has plunged by 179% from the previous quarter
The company's net income has shrunk by 174% QoQ

Key stats

What are the main financial stats of ARVN

ARVN stock price

How has the Arvinas stock price performed over time
Intraday
0.78%
1 week
-12.22%
1 month
-28.01%
1 year
11.65%
YTD
-34.57%
QTD
-26.79%

Financial performance

How have Arvinas's revenue and profit performed over time
Revenue
$89.4M
Gross profit
$89.4M
Operating income
-$253.7M
Net income
-$221.3M
Gross margin
100%
Net margin
-247.5%
The company's net income has shrunk by 174% QoQ
ARVN's operating income has plunged by 165% YoY and by 114% from the previous quarter
The gross profit has plunged by 79% YoY and by 66% from the previous quarter
Arvinas's revenue has plunged by 79% YoY and by 66% from the previous quarter

Price vs fundamentals

How does ARVN's price correlate with its fundamentals

Growth

What is Arvinas's growth rate over time

Valuation

What is Arvinas stock price valuation
P/E
N/A
P/B
1.28
P/S
5.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.72
The EPS has plunged by 179% from the previous quarter
The stock's price to book (P/B) is 59% less than its 5-year quarterly average of 3.1 and 9% less than its last 4 quarters average of 1.4
The company's equity fell by 41% YoY and by 11% QoQ
The P/S is 83% below the 5-year quarterly average of 31.6 but 53% above the last 4 quarters average of 3.6
Arvinas's revenue has plunged by 79% YoY and by 66% from the previous quarter

Efficiency

How efficient is Arvinas business performance

Dividends

What is ARVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARVN.

Financial health

How did Arvinas financials performed over time
ARVN's total assets is 148% more than its total liabilities
ARVN's total assets is down by 35% YoY and by 10% from the previous quarter
Arvinas's total liabilities has decreased by 24% YoY and by 8% from the previous quarter
The debt is 98% smaller than the equity
The company's equity fell by 41% YoY and by 11% QoQ
The debt has declined by 20% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.